Seeing Is Believing
Currently out of the existing stock ratings of Chris Howerton, 105 are a BUY (77.21%), 27 are a HOLD (19.85%), 4 are a SELL (2.94%).
Analyst Chris Howerton, currently employed carries an average stock price target met ratio of 50.98% that have a potential upside of 31.9% achieved within 147 days. Previously, Chris Howerton worked at JEFFERIES.
Chris Howerton’s has documented 279 price targets and ratings displayed on 41 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 18-Jan-2024.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 12/10/2020. The price target of $6 was fulfilled within 1 day with a profit of $0.22 (3.54%) receiving and performance score of 35.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$10.13 (60.05%)
$27
1 months 17 days ago
(07-Nov-2024)
8/22 (36.36%)
$9.79 (56.89%)
119
Buy
$28
$11.13 (65.98%)
$28
1 months 17 days ago
(07-Nov-2024)
0/4 (0%)
$10.79 (62.70%)
Hold
2 months 14 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$6.13 (36.34%)
$30
4 months 16 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$20
$3.13 (18.55%)
$28
4 months 17 days ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
What Year was the first public recommendation made by Chris Howerton?